Correlation Between Capricor Therapeutics and US Lithium

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Capricor Therapeutics and US Lithium at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Capricor Therapeutics and US Lithium into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Capricor Therapeutics and US Lithium Corp, you can compare the effects of market volatilities on Capricor Therapeutics and US Lithium and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Capricor Therapeutics with a short position of US Lithium. Check out your portfolio center. Please also check ongoing floating volatility patterns of Capricor Therapeutics and US Lithium.

Diversification Opportunities for Capricor Therapeutics and US Lithium

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Capricor and LITH is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Capricor Therapeutics and US Lithium Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on US Lithium Corp and Capricor Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Capricor Therapeutics are associated (or correlated) with US Lithium. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of US Lithium Corp has no effect on the direction of Capricor Therapeutics i.e., Capricor Therapeutics and US Lithium go up and down completely randomly.

Pair Corralation between Capricor Therapeutics and US Lithium

Given the investment horizon of 90 days Capricor Therapeutics is expected to generate 1.31 times more return on investment than US Lithium. However, Capricor Therapeutics is 1.31 times more volatile than US Lithium Corp. It trades about 0.08 of its potential returns per unit of risk. US Lithium Corp is currently generating about 0.05 per unit of risk. If you would invest  407.00  in Capricor Therapeutics on August 29, 2024 and sell it today you would earn a total of  1,497  from holding Capricor Therapeutics or generate 367.81% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Capricor Therapeutics  vs.  US Lithium Corp

 Performance 
       Timeline  
Capricor Therapeutics 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Capricor Therapeutics are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent basic indicators, Capricor Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.
US Lithium Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days US Lithium Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, US Lithium is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Capricor Therapeutics and US Lithium Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Capricor Therapeutics and US Lithium

The main advantage of trading using opposite Capricor Therapeutics and US Lithium positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Capricor Therapeutics position performs unexpectedly, US Lithium can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in US Lithium will offset losses from the drop in US Lithium's long position.
The idea behind Capricor Therapeutics and US Lithium Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Commodity Directory
Find actively traded commodities issued by global exchanges